INHIBITION OF ERYTHROCYTE SICKLING BY N-L-ALPHA-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER
摘要
It has now been found that N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM) exhibits antisickling properties. In vitro testing verified that APM significantly lowered the frequency of sickling of red blood cells from each of twelve pediatric aged patients being treated for sickle-cell anemia by exchange transfusion. Sickling was also inhibited in an "index" patient after oral administration of APM. These in vitro and in vivo results identify APM as a therapeutic agent for the family of sickle cell molecular diseases.
申请公布号
WO0018418(A3)
申请公布日期
2000.07.20
申请号
WO1999US22268
申请日期
1999.09.25
申请人
OKLAHOMA MEDICAL RESEARCH FOUNDATION;MANION, CARL, V.;EDMUNDSON, ALLEN, B.